The Trough That Never Came: A $986M Tariff Refund and an Earlier Margin Inflection Clear Nike's Overhang at Capitulation Lows

Results vs. Consensus — Q4 FY2026 (Fiscal Quarter Ended May 31, 2026)

Quality of Beat Assessment

Revenue beat: modest in magnitude, large in meaning. The $122M beat over the ~$10.85B consensus is small, roughly a point. Its significance is not the size of the beat but the gap between the actual and the disaster scenario the sell-side had been modeling into the print. Previews were, in the words of one, bracing for "more pain." Instead revenue fell only 1% reported and 4% currency-neutral, a deceleration from Q3's roughly flat print but a fraction of the mid-teens collapse investors had feared for the peak-tariff quarter. Currency was a roughly three-point tailwind (reported -1% vs. -4% currency-neutral), which will reverse in Q1 FY27 when FX turns neutral. The Nike Brand held flat on a reported basis at $10.7B.

Gross margin beat: real on the underlying, dominated by the accounting on the surface. The reported 49.2% is not a number to build a model on; the roughly 900 bps of IEEPA-recovery benefit inside it is a one-time credit for tariffs already expensed through the year. The number that matters is the 40.2% excluding the benefit, down only 10 bps year-over-year and better than management's own guide of down 25 to 75 bps. Management cited a fourth consecutive quarter of sequential margin improvement, driven by lower discounts, lower cancellations, and lower sales-related reserves, concentrated in North America. This is the cleanest genuinely-operational signal in the print: the promotional cleanup is working even as tariffs and mix work against it.

EPS beat: split it in two and grade each half. The reported $0.72 is inflated on two counts, the $0.52 tariff credit and a depressed prior-year base (Q4 FY25 earned just $0.14 on a kitchen-sink quarter), so the 414% growth is close to meaningless as a run-rate. The half that counts is the $0.20 adjusted figure, which beat the ~$0.12 consensus and grew 43% off that soft base. That beat was gross-margin and cost-discipline led, not tax- or buyback-manufactured: SG&A fell 2%, and buybacks were nearly paused ($123M for the year). A 19.6% tax rate helped versus the prior-year 33.6%, but the prior-year rate was itself distorted by low pre-tax income.

Segment Performance

*North America EBIT includes $965M of the $986M IEEPA tariff-recovery benefit; Converse includes $21M. Excluding the benefit, North America EBIT was roughly flat (down ~1%) and total Nike, Inc. EBIT was approximately $335M, a ~3.1% margin.

North America

North America is the proof of concept for the entire turnaround, and it delivered again: revenue up 3% to $4.8B, wholesale up 10%, and a milestone management flagged twice on the call, positive Nike revenue and retail-sales comps at Foot Locker for the first time in four years. Footwear led at up 4%, with performance categories (Running, Global Football, kids, golf) carrying the growth while Sportswear declined high single digits. The channel composition tells the strategic story: the recovery is wholesale-led, the deliberate result of Hill's marketplace-elevation playbook of rebuilding partner relationships, refreshing physical doors, and pulling back on the discounting that had alienated wholesale accounts.

"I remain very bullish on North America and their ability to continue to have sustainable growth moving forward." — Elliott Hill, President & CEO

The CFO added an important quality caveat: the reported +10% wholesale figure overstates the underlying demand signal, because a meaningful share of it came from lower returns, lower sales-related reserves, and fewer cancellations rather than higher sell-in.

"I want to make the point that we didn't sell in up 10%. A meaningful amount of that revenue growth was associated with lower returns or sales-related reserves and lower discount and lower cancellations. It's a healthier business in North America." — Matthew Friend, EVP & CFO

Assessment: North America is doing exactly what a leading-market turnaround should: growing on cleaner economics rather than promotional volume. The honesty about the sell-in versus reserve mix is a positive tell about earnings quality. The one yellow flag is the mid-April retail-sales deceleration management flagged, which it attributes partly to gas prices and consumer pressure; a Q2 FY27 wholesale-shipment-timing comp will also make the next few prints optically noisier.

Greater China

China remains the hardest problem on the page. Q4 revenue fell 17% currency-neutral to $1.3B, with wholesale down 19%, Nike Digital down 25%, and EBIT down 20% to $243M. This is a deeper decline than the roughly 7% we cited last quarter and confirms that the China issue is structural share loss to local champions, not a cyclical demand dip that time alone repairs. The constructive counterpoints are real but early: in-season sell-through improved sequentially, average retail discounts fell, inventory is down double digits, Running grew mid-single digits, Football and Tennis were up double digits, and the Shanghai House of Innovation posted double-digit growth.

"China is the second largest market today and will remain so. We have to get back to growth in China, we have to be more premium and culturally relevant, and we have to lead with Sport." — Elliott Hill, President & CEO

Management is standing up a Greater China local-for-local product team that will deliver locally designed, developed, and manufactured product in China by holiday calendar-2027, and it framed the near-term trajectory bluntly: revenue will stay in line with recent (deeply negative) performance for now, but profitability should bottom before sales.

Assessment: China is still the largest single risk to the numbers, roughly 13-14% of revenue shrinking double digits, and holiday-2027 local product is a long runway. But the inventory cleanup, discount discipline, and the "profitability bottoms before sales" framing are how a genuine reset looks in its early innings. We treat China as a drag to be contained rather than a value to be underwritten, and note that consensus still likely embeds too much China recovery in the out-years.

EMEA and APLA

EMEA fell 6% currency-neutral, with the story concentrated in a promotional cleanup: off-price was down more than 50% following aggressive action to cut promotions, producing a 15-point improvement in full-price realization. That is margin-accretive medicine that suppresses near-term revenue, and inventory up low double digits means the region has more liquidation work ahead. APLA was the quiet stabilizer, down just 1% currency-neutral with Running and Global Football up double digits and Nike-owned stores actually up 2%.

Assessment: EMEA is running the same full-price-reset playbook that North America ran a few quarters earlier, so its revenue softness is more self-inflicted (and margin-positive) than demand-driven. APLA is the least-discussed geography precisely because it is the least broken. Neither changes the thesis, but both support the read that the promotional cleanup is a company-wide, deliberately margin-first program.

Converse

Converse fell 34% currency-neutral to $244M, a run-rate now under $1.2B annually against a business that once cleared $2B, with declines across every territory. Unlike prior quarters, though, management gave it a strategy rather than silence: Converse will focus on the Chuck Taylor and Jack Purcell lifestyle franchises and its creator community, and the signing of Shai Gilgeous-Alexander to Nike Basketball (rather than Converse) was explicitly framed as freeing Converse to focus on lifestyle instead of performance.

Assessment: A sharper, narrower Converse mandate is an improvement over the drift we criticized last quarter, but at $244M and falling it is now immaterial to consolidated revenue and near-immaterial to EBIT ($23M, and that included a $21M tariff credit, so roughly breakeven on an operating basis). The right way to model Converse is as a small, still-shrinking option, not a contributor.

Key KPIs

Key Topics & Management Commentary

Overall Management Tone: Steadier and more forward-leaning than a quarter ago, without tipping into victory laps. Hill anchored the call on the decade rather than the quarter, repeatedly conceding that "the results aren't there yet" while pointing to structural progress, and the CFO paired that with the most concrete margin-inflection language in two years. The posture on the two open sores, China and Sportswear, was candid rather than evasive; the notable absence of confidence was around the macro and the consumer, which management flagged as decelerating since mid-April.

The IEEPA Tariff Recovery: A $986M Swing

The defining financial event of the quarter is not operational. On February 20, 2026, the U.S. Supreme Court ruled that tariffs imposed under the International Emergency Economic Powers Act were unauthorized. In Q4, Nike judged recovery of the IEEPA tariffs it had paid to be probable and booked a $986M benefit, offsetting the IEEPA cost embedded in cost of sales across fiscal-2026. Over $300M was collected in cash by quarter-end; the rest sits in accounts receivable, which is why receivables jumped 26%.

"We determined that the financial recovery of claims related to incremental tariffs paid under IEEPA had become probable. This resulted in the recognition of a one-time benefit of $986 million... Tariffs remain a dynamic cost headwind that we expect to continue looking forward." — Matthew Friend, EVP & CFO

Assessment: This is the most important line in the thesis and the most misunderstood in the reaction. It is a one-time credit, so it should be excluded from run-rate earnings. But its meaning is not one-time: the $1.5B annualized tariff burden that anchored the bear case for a year has been substantially defanged, both retrospectively (the refund) and prospectively (management's Q1 guide now assumes only a 10-15% incremental rate, not the punitive IEEPA regime). The overhang did not just shrink; its legal basis was struck down.

The Trough That Didn't Arrive

Coming into this print, the widely-held expectation was that the May quarter would mark Nike's earnings trough, the point of maximum tariff absorption and maximum margin compression. What actually printed was a 40.2% ex-benefit gross margin down only 10 bps, a fourth straight quarter of sequential margin improvement, and revenue down 1% reported. The feared step-down did not materialize because the tariff cost was recovered and the promotional cleanup outran the mix headwinds.

"Our performance this quarter has given us increasing confidence that our margins are stabilizing and that we're starting to see a pathway back towards gross margin expansion." — Matthew Friend, EVP & CFO

Assessment: When the worst-case quarter comes in benign, the risk distribution around the stock changes even if the point estimate does not. This is the mechanism behind our upgrade: the event that the bear case needed to go right, went wrong for the bears.

The Sport Offense and the Performance Halo

Hill's organizing framework is now the "Sport Offense," roughly 8,000 employees reorganized into vertical sport teams, layered on top of the "Win Now" stabilization actions that will sunset by the end of calendar-2026. The thesis is that authentic wins in performance sport create a halo that eventually lifts Sportswear and Jordan Streetwear, the roughly-half of revenue that is still declining. Running is the proof: five consecutive quarters of double-digit growth, five points of statement-footwear share gained, and specific product wins (the PEG 42, the Mercurial's record 24-hour Nike Direct launch, Aero-FIT kits selling 2.5x the prior World Cup).

"When we lead with sport authentically, consumers respond... When those dimensions connect, they create the NIKE multiplier. It's repeatable and sustainable." — Elliott Hill, President & CEO

Assessment: The performance-first strategy is intellectually coherent and is demonstrably working in Running. The open question is transfer: whether performance credibility actually re-ignites Sportswear, or whether the two halves of the portfolio move independently. Management concedes the halo has not yet reached Sportswear. Spring-2027 is the first season that will carry product from the new cross-functional teams end-to-end, so that is the real test date.

Sportswear and Jordan Streetwear: The Demand Problem

The candid low point of the call was management's admission on the roughly 50% of revenue that is lifestyle. Sportswear declined double digits in the quarter, with a similar decline in retail sales, and management expects Sportswear and Jordan Streetwear to stay negative through fiscal-2027 with improvement only in the back half. Nike pulled more than $2B of classic footwear franchises out of the market in FY26 to reduce the discount-driven, sell-through-challenged inventory that had been feeding the marketplace.

"We know we're not living up to our full potential, particularly in NIKE Sportswear and Jordan Streetwear, where sell-through remains challenged, impacting both current discounting and future order books." — Elliott Hill, President & CEO

Assessment: This is the counterweight to the margin optimism. Half the business is guided negative for another year, and the fix (more than a dozen new Sportswear footwear silhouettes in the second half of FY27, built on innovation rather than retro re-releases) is unproven and back-half weighted. The good news is that the deliberate $2B franchise reduction is exactly the short-term-pain, medium-term-health medicine a credible reset requires; the bad news is that it keeps the top line negative while it heals.

Margin Inflection and Structural Supply-Chain Cost-Out

The most consequential forward statement was the pull-forward of the gross-margin inflection. Management now guides Q1 FY27 gross margin "slightly positive," an expansion, driven by the North America discount improvement and by structural supply-chain actions taken in Q3 and Q4: fewer facilities, a smaller workforce, and a re-engineered flow of product from factory to retail. Those costs largely hit FY26; the benefits accrue in FY27 and are the bridge management draws toward its reiterated goal of double-digit operating margins.

"We've had 4 quarters of sequential improvement in our margins... The actions we took in Q3 and Q4 were the initial steps... we expect those to drive margin expansion in fiscal year '27 and contribute to this trajectory to get back to double-digit margins." — Matthew Friend, EVP & CFO

Assessment: This is the fulcrum of the upgraded thesis. A business whose revenue is flat-to-slightly-negative can still re-rate powerfully if gross margin turns from contraction to expansion, because the market pays for the earnings trajectory, not the revenue trajectory. Guiding an earlier-than-expected inflection, with a named structural cost program behind it, is the credible recovery arc our prior note said we were waiting for.

The CFO Transition

This was Matthew Friend's last earnings call after nearly 18 years, his final years spent steering the company through the demand reset and tariff shock. His successor, David Denton, starts August 17, arriving from the Pfizer CFO seat with prior CFO tenures at Lowe's and CVS Health. Friend departs September 4 after supporting the handoff.

Assessment: The market's instinct to treat a CFO change mid-turnaround as reset risk (one desk cut its target citing exactly that) is understandable but, in our read, backwards. Denton is a large-cap capital-allocation and operational-finance veteran of two hard consumer/retail turnarounds. Bringing that skill set in precisely as the story shifts from stabilization to margin recovery and capital deployment is more feature than bug. The transition does raise the near-term communication bar, and a new CFO often rebases guidance, which is a risk into the November Investor Day.

Capital Allocation Through the Trough

Nike returned about $2.5B to shareholders in FY26, but the composition was defensive: $2.4B in dividends (raised 5%) against just $123M of buybacks, 1.8M shares, a near-complete pause of repurchases under the four-year $18B authorization. Cash and short-term investments ended at $9.0B, down only $0.1B despite the dividend and capex, helped by the $0.3B of tariff cash already collected. A $2B note moved into current liabilities, and long-term debt fell 25%.

Assessment: Pausing buybacks to protect the balance sheet and dividend through the earnings trough is the correct sequencing, and it leaves substantial dry powder ($18B authorization, largely untapped) to lean into once earnings visibility improves. With the stock at 52-week lows and the tariff cash flowing back in, the resumption of meaningful repurchase is a plausible catalyst that a new capital-allocation-minded CFO may accelerate. This is a quiet but real part of the Outperform case.

Guidance & Outlook

The framework is deliberately modest on the top line and deliberately constructive on margin. Management reiterated its expectation for earnings to be roughly flat over the three quarters from Q4 FY26 through Q2 FY27 (excluding the tariff benefit), while conceding the composition has shifted toward softer revenue as it tightens buys and reduces sell-in in response to the mid-April sell-through deceleration. The offset is an earlier margin inflection: gross margin expanding from Q1, funded by North America discount improvement and the structural supply-chain cost-out.

Implied read: A business guided to roughly flat earnings with revenue down low-to-mid single digits and gross margin turning positive is, in plain terms, a company that has stopped getting worse and has begun trading revenue for margin quality. The tariff assumption embedded in the Q1 guide, incremental rates of 10% through the end of July then 15% thereafter, is materially lighter than the punitive IEEPA regime the model previously carried.

Street at: Consensus was braced for a weaker quarter and a vaguer outlook. Expect FY27 EPS estimates to firm modestly around a $1.75-2.10 range (ex one-timers) as the margin-expansion guide is absorbed, though the biggest revisions wait for the November Investor Day, when a full-year framework and the longer-term margin target should replace the current three-quarter window.

Guidance style: This is a management team that has consistently guided conservatively on gross margin and beaten (Q4 came in above its own -25 to -75 bps guide), so the "slightly positive" Q1 margin guide should be read as a floor, not a stretch. The revenue guide carries less embedded conservatism and should be taken closer to face value given the flagged consumer softness.

Analyst Q&A Highlights

Getting Sportswear Back to Full-Price Growth

The opening line of questioning pressed on the central tension in the strategy: if Nike is pulling back inventory and insisting on full-price selling in a category (Sportswear) that has struggled to sell through at full price, how does the performance success actually halo across to fix it? Management leaned into the Sport Offense as the differentiator versus fashion brands, and pointed to dedicated Sportswear teams and more than a dozen new footwear silhouettes coming in the back half of FY27.

Q: "I'm just trying to figure out how much R&D and innovation investment is going into the Sportswear category to drive future growth. If you're pulling back on inventory and focusing on full price selling, having struggled in full price selling, just wondering how you can get the performance success to halo out to Sportswear."
— Adrienne Yih, Barclays

A: "Our point of differentiation is our sport business, and that creates the halo over both of those brands... In the second half of FY '27, Sportswear is going to introduce more than a dozen new footwear styles, not just going back to the vault and doing old retro shoes, but leveraging innovation with newness and freshness in new silhouettes... In the end, it's going to take time to scale, but I'm confident in the work the teams are doing."
— Elliott Hill, President & CEO

Assessment: Management answered the "what" (dedicated teams, new innovation-led silhouettes) but not the "when it works" (timeline to Sportswear inflection beyond a vague back-half FY27). The honesty that it "will take time to scale" is credible; the lack of a measurable milestone is the frustration. This is the single biggest unproven leg of the thesis.

The Q1-to-Q2 Revenue Bridge

A recurring line of questioning sought to reconcile the Q4 print with the guided deceleration, and specifically why Q2 FY27 would step down further from Q1. Management attributed the sequential path primarily to mechanical comparison effects rather than a deterioration in the underlying business.

Q: "Just on the numbers, could you help us bridge the drivers of first quarter revenue being down low to mid-single digits and further moderation in the second quarter relative to the negative 1% decline here in the fourth quarter?"
— Matthew Boss, JPMorgan

A: "The biggest driver in Q1 versus Q4 is the fact that FX will no longer be a tailwind to revenue... As it relates to Q2, the two largest factors equating to a multipoint headwind were much higher levels of digital promotions in EMEA in Q2 last year... and extraordinarily high wholesale growth in North America in Q2 last year, also related to timing anomalies."
— Matthew Friend, EVP & CFO

Assessment: A reassuring answer. The Q1 step-down is FX translation, not demand, and the Q2 deceleration is comp-driven (a prior-year EMEA promotion the company is deliberately not repeating, plus wholesale-shipment timing). Investors should look through the reported Q2 trough rather than extrapolate it, which is exactly why management pre-flagged it.

China's Reset and the Digital Cleanup

Questioning on Greater China focused on the shape of the recovery, particularly the direct-to-consumer and digital businesses given the physical-fleet renovations underway. Management reaffirmed China as the second-largest market and a non-negotiable long-term priority, while being explicit that the near-term revenue trajectory stays weak even as profitability and full-price realization improve first.

Q: "I was hoping you could go into a little more detail on your China strategy... how are you thinking about the direct-to-consumer, particularly the digital business from here?"
— Lorraine Hutchinson, Bank of America

A: "We're seeing recovery in full price realization on digital... We do expect that the revenue trends in Greater China over the near term will be in line with our recent performance. And we continue to believe that profitability will bottom before sales in this market."
— Matthew Friend, EVP & CFO

Assessment: "Profitability bottoms before sales" is the key disclosure. It tells you management is managing China for margin and inventory health first and revenue second, which is the right sequence but implies revenue stays negative for several more quarters. Holiday-2027 local-for-local product is the demand catalyst, and it is a long way off.

Where the Turnaround Stands and When "Normal" Returns

One exchange sought a direct read on the innings of the turnaround, including whether fiscal-2028 could be the first "normal" operating year. Management declined to timestamp normalization, reframing around the sequenced Win Now actions (culture, brand, product, then marketplace execution) that sunset at the end of calendar-2026 and hand off to the Sport Offense.

Q: "About 6 months ago, you talked about being in the middle innings on the turnaround. Can you give us an update on where you're at? And do you expect FY '28 to be the first normal year of operations?"
— Aneesha Sherman, Bernstein

A: "I don't think there's been anything normal since I've sat in this chair... We remain on track to sunset the Win Now actions by the end of this calendar year... We're not building this business for the next quarter or the next year, we're building it for the decade to come."
— Elliott Hill, President & CEO

Assessment: A polished non-answer on the FY28 normalization question, deferred to the November Investor Day. The refusal to anchor a "normal year" is defensible given macro uncertainty but keeps the market's normalized-earnings estimate a matter of faith rather than guidance. This is the gap the Investor Day must close.

The Drivers Behind the Earlier Margin Inflection

A pointed follow-up asked management to itemize the margin-expansion drivers beyond simple operating leverage, given the guided faster inflection. The answer was unusually specific for a company that has spent a year being vague about the margin path.

Q: "You guided for a faster inflection in margins than before. Can you walk through some of the main drivers of this margin inflection aside from operating leverage?"
— Aneesha Sherman, Bernstein

A: "The biggest driver was discount improvement in North America, lower sales-related reserves, lower cancellations and lower discounts... we highlighted a meaningful opportunity to structurally improve our gross margins, really focused on taking cost out of our supply chain and the make of our product... we expect those to drive margin expansion in fiscal year '27."
— Matthew Friend, EVP & CFO

Assessment: This is the most important answer of the call. Two distinct, durable levers, promotional discipline and structural supply-chain cost-out, rather than one-time or mix-dependent benefits. It converts the "path to double-digit margins" from a slogan into a mechanism, and it is why we are comfortable underwriting margin expansion even with revenue negative.

North America Wholesale Durability

A final line of questioning probed whether North America wholesale, up 10% in Q4, could decline in any quarter of FY27 given the sell-in and point-of-sale commentary. Management expressed confidence in North America's leadership of the comeback while candidly flagging a tough Q2 compare and reiterating the reserve-versus-sell-in quality caveat.

Q: "Are there any quarters next fiscal year where you're expecting North America wholesale to decline, just based on the sell-in and some of the comments you made on POS? Can you help shape that, at least for the first half?"
— Ike Boruchow, Wells Fargo

A: "Q2 does have a tough compare in North America. Without getting into the specificities of every quarter, we continue to believe North America is leading our progress... this quarter was the first quarter we grew both NIKE revenue plus NIKE retail sales in Foot Locker in over 4 years. We're on the right path."
— Matthew Friend, EVP & CFO

Assessment: Management would not rule out a down wholesale quarter in the first half, which is prudent given the comp. The Foot Locker milestone is the substantive positive, evidence the wholesale re-engagement is producing genuine sell-through, not just sell-in. North America durability is the load-bearing wall of the whole recovery, and it is holding.

What They're NOT Saying

1. No full fiscal-2027 outlook: Management gave a three-quarter earnings framework and a Q1 guide but withheld a full-year revenue, margin, or EPS outlook, deferring it to the November 16-17 Investor Day. The stock cannot fully re-rate on a partial framework; the real anchor is five months out.
2. No Sportswear inflection date: "Improvement in the back half of FY27" is the only marker offered for roughly half the business. No revenue target, no quarter, no measurable milestone for when Sportswear and Jordan Streetwear stop being a drag.
3. No China revenue-recovery timeline: Management will commit to "profitability bottoms before sales" and holiday-2027 local product, but not to when China revenue returns to growth. Given China is the largest single risk, the continued refusal to timestamp it is conspicuous.
4. The receivables build went unaddressed: Accounts receivable rose 26% to $5.9B, driven by the ~$686M tariff recovery still uncollected. Management noted $300M collected but did not detail the timing or any collection risk on the remainder, a real (if probable) balance-sheet asset that now depends on the tariff-refund process completing.
5. No explicit normalized-earnings power: Hill deflected the "first normal year" question entirely. Without a normalized-margin or normalized-EPS anchor, the valuation debate remains a debate about faith in the decade-long thesis rather than a calculation off guided numbers.
6. Buyback resumption left open: With repurchases paused at $123M and $18B authorized, management did not signal when meaningful buybacks resume, arguably the clearest near-term capital-return catalyst, and a natural question for the incoming CFO.

Market Reaction

• Pre-print setup: Shares closed the print day (June 30) at $41.05, near the bottom of a 52-week range of $40.75 to $79.24, down 35.6% year-to-date and 42.2% over the trailing twelve months against an S&P 500 up 9.6% YTD. The stock entered the print as one of the most-hated large-cap consumer names, a washed-out setup.
• After-hours move: The initial reaction was negative, shares fell as much as 8% in extended trading on the soft FY27 revenue framing, the guided continuation of a roughly 17% China decline, and caution over the CFO change, before recovering much of the loss as investors digested the averted trough and the tariff recovery.
• Reaction-day session (July 1): Shares closed up 4.9% at $43.06 on 80.2M shares, 3.4x the 30-day average volume, a decisive positive turn once the market weighed the margin inflection and cleared overhang against the still-soft top line.
• Sentiment marker: A prominent retail-facing commentator's charitable trust fully exited the position at roughly $41 on the print, framing it as a "make or break" quarter that broke. Capitulation from that corner is often a contrarian tell near a bottom.

The round trip, down 8% then up 5%, is the single most informative thing about the reaction. The knee-jerk was to sell the soft revenue guide and the tariff-flattered headline; the considered response was to buy an averted trough, a cleared tariff overhang, and an earlier margin inflection at a 52-week-low valuation. That the second impulse won, on 3.4x volume, suggests real money re-engaged rather than a short-covering bounce. With the stock still about 39% below where it traded a year ago and sentiment visibly capitulating, the risk/reward of the setup shifted in the buyer's favor.

Street Perspective

Debate: Is the EPS Beat Real or an Accounting Illusion?

Bull view: Strip the tariff credit and the quarter still beat: $0.20 adjusted versus ~$0.12 consensus, on a 40.2% gross margin better than the guide, with a fourth straight quarter of sequential margin gains. The beat is operational, not manufactured.

Bear view: The reported $0.72 and 49.2% gross margin are noise, and even the $0.20 "clean" number benefits from a soft prior-year base and paused buybacks. The core business shrank, China worsened, and half the portfolio is guided negative for another year.

Our take: Both are right about their half; the bull has the more decision-relevant half. The market pays for margin trajectory, and the underlying margin turned the corner. We would not own Nike for this quarter's earnings; we would own it for the margin path this quarter validated.

Debate: Does the Tariff Refund Change the Thesis or Just the Quarter?

Bull view: It changes the thesis. The $1.5B annualized tariff burden was the largest quantifiable overhang; the Supreme Court struck down its legal basis, Nike is recovering the cash, and the go-forward tariff assumption is a fraction of the prior regime. A whole leg of the bear case was removed.

Bear view: It changes only the quarter. Management explicitly said tariffs "remain a dynamic cost headwind," the Q1 guide still assumes a 10-15% incremental rate, and trade policy could shift again. The refund is a one-time cash event, not a structural margin improvement.

Our take: Closer to the bull. Even if tariffs persist at a lower rate, the tail-risk scenario, a punitive rate crushing margins indefinitely, has been materially de-risked by the legal ruling. Removing a tail risk is worth a re-rating even if the base case is unchanged.

Debate: Can Nike Re-Rate with Revenue Still Negative?

Bull view: Yes, and this is the point. Turnarounds re-rate on the earnings inflection, not the revenue inflection. With gross margin guided to expand from Q1 and a structural cost program behind it, EPS can grow on flat-to-down revenue, and a stock at 52-week lows has the valuation room to re-rate on that alone.

Bear view: No. A consumer brand with declining revenue, a shrinking China, half its portfolio in secular decline, and a decelerating consumer does not deserve a premium multiple, and $43 on ~$1.6-2.10 of normalized-ish EPS is not cheap enough to compensate.

Our take: The bull framing is correct on the mechanism and this is precisely where our prior Hold was too cautious. We were burned a year ago upgrading on a single quarter of positive revenue that China then reversed; we are deliberately not repeating that. This upgrade does not require revenue to inflect. It requires margins to inflect (guided), the overhang to clear (done), and the valuation to be washed out (it is). Those three are in hand.

Debate: Is the New CFO a Risk or an Upgrade?

Bull view: Denton is a proven large-cap turnaround CFO (Lowe's, CVS, Pfizer) arriving exactly as the story pivots from stabilization to margin recovery and capital deployment. That is the right skill set at the right moment, and a fresh set of eyes on the $18B buyback is a plus.

Bear view: A CFO change mid-turnaround is destabilizing, risks a guidance rebase at the November Investor Day, and cost Friend's institutional knowledge of a uniquely complex tariff-and-China situation.

Our take: Net positive, with a near-term communication risk. The rebase risk is real but cuts both ways; a new CFO often clears the decks conservatively, creating a lower bar. We would treat any Investor-Day rebase weakness as an opportunity, not a thesis-breaker.

Model Update Needed

Valuation impact: At $43, Nike trades at roughly 20x reported FY26 EPS ($2.10) and ~27x the $1.58 ex-benefit figure, optically full on trough earnings. The Outperform case does not rest on the trailing multiple; it rests on the forward path. On a normalized earnings power of $3.00-4.00 per share (below the prior through-cycle peak, reflecting a structurally smaller China and Converse) and a 22-26x multiple appropriate for a re-accelerating global brand, fair value lands in the $75-100 range over a 24-month horizon. Consensus price targets cluster around $53-60 (implying roughly +23% to +40% from $43). We see the 12-month path to the low end of that range as well-supported by the margin inflection alone, with the November Investor Day as the catalyst to close the gap to normalized value.

Thesis Scorecard Post-Earnings

Overall: Thesis strengthened. The two bull pillars that drive the stock from here (margin inflection and North America) are confirmed, the largest bear pillar (tariffs) has been reversed, and the valuation is at capitulation lows. The residual bear pillars (China, Sportswear, transition) are real but are drags to be contained rather than value to be underwritten, and they are more than priced at 52-week lows.

Action: Upgrade to Outperform. Accumulate at current levels, with the November 16-17 Investor Day as the next catalyst to close the gap toward normalized value. Add on any transition-related or Investor-Day rebase weakness. The one thing that would send us back to Hold is evidence the margin inflection is slipping (a Q1 FY27 gross margin that fails to expand) or a further leg down in China that pressures the consolidated margin path.